These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 28739713)
1. Feasibility of Postoperative Radiotherapy Using Conventional Fractionation for Lymph Node Metastasis from Cutaneous Melanoma. Kim YJ; Song SY; Kim W; Jeong SY; Choi W; Je HU; Lee JS; Choi EK Anticancer Res; 2017 Aug; 37(8):4239-4246. PubMed ID: 28739713 [TBL] [Abstract][Full Text] [Related]
2. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589 [TBL] [Abstract][Full Text] [Related]
3. A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma. Ballo MT; Zagars GK; Gershenwald JE; Lee JE; Mansfield PF; Kim KB; Camacho LH; Hwu P; Ross MI Ann Surg Oncol; 2004 Dec; 11(12):1079-84. PubMed ID: 15576833 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant irradiation for axillary metastases from malignant melanoma. Ballo MT; Strom EA; Zagars GK; Bedikian AY; Prieto VG; Mansfield PF; Lee JE; Gershenwald JE; Ross MI Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):964-72. PubMed ID: 11958890 [TBL] [Abstract][Full Text] [Related]
5. Regional control of melanoma neck node metastasis after selective neck dissection with or without adjuvant radiotherapy. Hamming-Vrieze O; Balm AJ; Heemsbergen WD; Hooft van Huysduynen T; Rasch CR Arch Otolaryngol Head Neck Surg; 2009 Aug; 135(8):795-800. PubMed ID: 19687401 [TBL] [Abstract][Full Text] [Related]
6. Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma. Beadle BM; Guadagnolo BA; Ballo MT; Lee JE; Gershenwald JE; Cormier JN; Mansfield PF; Ross MI; Zagars GK Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1376-82. PubMed ID: 18774657 [TBL] [Abstract][Full Text] [Related]
7. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma. Agrawal S; Kane JM; Guadagnolo BA; Kraybill WG; Ballo MT Cancer; 2009 Dec; 115(24):5836-44. PubMed ID: 19701906 [TBL] [Abstract][Full Text] [Related]
8. Surgery and adjuvant radiotherapy for cutaneous melanoma considered high-risk for local-regional recurrence. Mendenhall WM; Shaw C; Amdur RJ; Kirwan J; Morris CG; Werning JW Am J Otolaryngol; 2013; 34(4):320-2. PubMed ID: 23375588 [TBL] [Abstract][Full Text] [Related]
9. Adjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: is there any benefit for high-risk patients? Moncrieff MD; Martin R; O'Brien CJ; Shannon KF; Clark JR; Gao K; McCarthy WM; Thompson JF Ann Surg Oncol; 2008 Nov; 15(11):3022-7. PubMed ID: 18958539 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial. Henderson MA; Burmeister BH; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF Lancet Oncol; 2015 Sep; 16(9):1049-1060. PubMed ID: 26206146 [TBL] [Abstract][Full Text] [Related]
11. Sphincter-sparing local excision and hypofractionated radiation therapy for anorectal melanoma: a 20-year experience. Kelly P; Zagars GK; Cormier JN; Ross MI; Guadagnolo BA Cancer; 2011 Oct; 117(20):4747-55. PubMed ID: 21446049 [TBL] [Abstract][Full Text] [Related]
12. Patterns of Recurrence in Patients with Stage IIIB/C Cutaneous Melanoma of the Head and Neck Following Surgery With and Without Adjuvant Radiation Therapy: Is Isolated Regional Recurrence Salvageable? Barbour S; Mark Smithers B; Allan C; Bayley G; Thomas J; Foote M; Burmeister B; Barbour AP Ann Surg Oncol; 2015 Nov; 22(12):4052-9. PubMed ID: 25582744 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant radiotherapy for palpable melanoma metastases to the groin: when to irradiate? Gojkovič-Horvat A; Jančar B; Blas M; Zumer B; Karner K; Hočevar M; Strojan P Int J Radiat Oncol Biol Phys; 2012 May; 83(1):310-6. PubMed ID: 22035662 [TBL] [Abstract][Full Text] [Related]
16. Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study. Mozzillo N; Pasquali S; Santinami M; Testori A; Di Marzo M; Crispo A; Patuzzo R; Verrecchia F; Botti G; Montella M; Rossi CR; Caracò C Eur J Surg Oncol; 2015 Jul; 41(7):823-9. PubMed ID: 25800935 [TBL] [Abstract][Full Text] [Related]
18. Local control in sinonasal malignant melanoma: Comparing conventional to hypofractionated radiotherapy. Lansu J; Klop WM; Heemsbergen W; Navran A; Al-Mamgani A; Langendijk JA; Kaanders JH; Terhaard C; Karakullukcu B; Hamming-Vrieze O Head Neck; 2018 Jan; 40(1):86-93. PubMed ID: 29044881 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant radiation therapy after axillary lymphadenectomy for metastatic melanoma: toxicity and local control. Strom EA; Ross MI Ann Surg Oncol; 1995 Sep; 2(5):445-9. PubMed ID: 7496841 [TBL] [Abstract][Full Text] [Related]
20. Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications. Bastiaannet E; Beukema JC; Hoekstra HJ Cancer Treat Rev; 2005 Feb; 31(1):18-26. PubMed ID: 15707701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]